sirolimus and Fasciitis

sirolimus has been researched along with Fasciitis* in 2 studies

2 other study(ies) available for sirolimus and Fasciitis

Article	Year
Eosinophilic Fasciitis Triggered by Nivolumab: A Remarkable Efficacy of the mTOR Inhibitor Sirolimus. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2020, Volume: 15, Issue:2 Topics: Eosinophilia; Fasciitis; Humans; Lung Neoplasms; Nivolumab; Sirolimus; TOR Serine-Threonine Kinases	2020
Treatment of Eosinophilic Fasciitis With Sirolimus. JAMA dermatology, 2016, Volume: 152, Issue:4 Topics: Adult; Eosinophilia; Fasciitis; Humans; Immunosuppressive Agents; Male; Sirolimus; Treatment Outcome	2016